KIMBERLY JETER: Open Payments
NPI 1932945060 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 49 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $684 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $221 |
| Novo Nordisk Inc | 9 | $148 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Sumitomo Pharma America, Inc. | 3 | $77 |
| Verity Pharmaceuticals Inc. | 3 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| Amgen Inc. | 4 | $55 |
| PFIZER INC. | 2 | $45 |
| Astellas Pharma US Inc | 1 | $30 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
Products named: UBRELVY, GEMTESA, Tlando, JARDIANCE, QULIPTA, Wegovy, LINZESS, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
